首页> 美国卫生研究院文献>Biomedicines >Stem Cell Therapies for Treatment of Liver Disease
【2h】

Stem Cell Therapies for Treatment of Liver Disease

机译:干细胞疗法治疗肝病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell therapy is an emerging form of treatment for several liver diseases, but is limited by the availability of donor livers. Stem cells hold promise as an alternative to the use of primary hepatocytes. We performed an exhaustive review of the literature, with a focus on the latest studies involving the use of stem cells for the treatment of liver disease. Stem cells can be harvested from a number of sources, or can be generated from somatic cells to create induced pluripotent stem cells (iPSCs). Different cell lines have been used experimentally to support liver function and treat inherited metabolic disorders, acute liver failure, cirrhosis, liver cancer, and small-for-size liver transplantations. Cell-based therapeutics may involve gene therapy, cell transplantation, bioartificial liver devices, or bioengineered organs. Research in this field is still very active. Stem cell therapy may, in the future, be used as a bridge to either liver transplantation or endogenous liver regeneration, but efficient differentiation and production protocols must be developed and safety must be demonstrated before it can be applied to clinical practice.
机译:细胞疗法是几种肝脏疾病的新兴治疗形式,但受到供体肝脏可用性的限制。干细胞有望替代原代肝细胞。我们对文献进行了详尽的回顾,重点是涉及使用干细胞治疗肝病的最新研究。干细胞可以从许多来源中收获,或者可以从体细胞中产生,以产生诱导性多能干细胞(iPSC)。实验中已经使用了不同的细胞系来支持肝功能,并治疗遗传性代谢异常,急性肝衰竭,肝硬化,肝癌和小型肝移植。基于细胞的疗法可能涉及基因疗法,细胞移植,生物人工肝装置或生物工程器官。该领域的研究仍然非常活跃。将来,干细胞疗法可被用作肝移植或内源性肝再生的桥梁,但必须开发有效的分化和生产方案,并且必须证明其安全性,然后才能将其应用于临床实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号